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OBJECTIVES Very early changes in myocardial tissue composition during acute myocardial infarction
(AMI) are difficult to assess in vivo. Cardiovascular magnetic resonance (CMR) imaging
provides techniques for visualizing tissue pathology.
BACKGROUND The diagnostic role of CMR in very acute stages of myocardial infarction is uncertain. We
investigated signal intensity changes beginning within 60 min after acute coronary occlusion
in patients undergoing therapeutic septal artery embolization.
METHODS We investigated eight patients with hypertrophic obstructive cardiomyopathy undergoing
interventional septal artery embolization by applying microparticles to reduce left ventricular
outflow tract obstruction. In a clinical 1.5-tesla (T) CMR system, we visualized infarct-
related myocardial signal by T1-weighted sequences before and 20 min after administration
of contrast media (delayed enhancement) and edema-related signal by T2-weighted spin-echo
sequences before and 58  14 min after the intervention as well as on days 1, 3, 7, 14, 28,
90, and 180 during follow-up.
RESULTS Infarct-related changes as defined by contrast enhancement were observed as early as 1 h after
the intervention and during six months of follow-up. In contrast, infarct-related myocardial
edema, as visualized by high signal intensity in T2-weighted spin-echo sequences, was not
consistently detectable 1 h after acute arterial occlusion; this was possible in all subsequent
studies until day 28.
CONCLUSIONS Contrast-enhanced magnetic resonance imaging detected infarct-related signal changes as
early as 1 h after AMI in humans, whereas the sensitivity of edema-related signal changes was
not sufficient during this very early stage. (J Am Coll Cardiol 2003;42:513–8) © 2003 by
the American College of Cardiology Foundation
The early and reliable diagnosis of acute myocardial infarc-
tion (AMI) has a strong impact on clinical outcomes (1).
Current clinical routine is mostly based on medical history,
physical status, the electrocardiogram (ECG), and serologic
findings. Although the overall sensitivity of these parame-
ters is good (2,3), it is less favorable early after the onset of
ischemia (4). However, in the diagnosis of myocardial
infarction (MI), speed is essential, and in selected patients
with equivocal results, the knowledge of very early changes
could be helpful in therapeutic decision-making.
Cardiovascular magnetic resonance (CMR) is able to
differentiate infarcted from normal myocardium (5–7) and
also detects myocardial edema by T2-weighted pulse se-
quences (8,9). However, in most animal and human studies
(10,11), the changes were assessed at least 24 h after the
acute injury. We investigated the signal intensity changes in
the very early stages of MI after acute occlusion of a
coronary artery.
METHODS
Patients. We studied eight patients (5 men and 3 women;
41 to 78 years old) with hypertrophic obstructive cardiomy-
opathy scheduled for interventional septal artery emboliza-
tion. All patients had severe symptoms with dyspnea (New
York Heart Association [NYHA] functional class III or
IV), despite optimized pharmacologic treatment, and ful-
filled the accepted criteria for undergoing this intervention.
Significant coronary artery disease was excluded by cardiac
catheterization. All patients gave written, informed consent.
One patient was embolized a second time three months
after the first procedure because severe symptoms and a high
pressure gradient persisted.
Septal artery embolization. The intervention was per-
formed by infusion of a solution containing microparticles
(Contour Emboli; Target, Boston Scientific Corp., Boston,
Massachusetts) into the septal artery supplying the basal
septum as identified by intra-procedural contrast-enhanced
echocardiography. The infusion resulted in acute embolic
occlusion of the artery with complete cessation of flow, thus
closely matching the pathophysiology of thrombotic occlu-
sion in atherosclerotic AMI.
CMR imaging. We used a dedicated CMR system (Signa
CV/i; 1.5 T, GE Medical Systems, Milwaukee, Wisconsin)
located close to the cardiac catheterization laboratory and
intensive care unit. Patients were continuously monitored
during the examination by ECG, repeated blood pressure
measurements, and pulse oximetry.
We used a four-element, phased-array coil or body coil. A
T2-weighted spin-echo sequence (short T1 inversion recov-
ery [STIR], repetition time [TR] 2 RR interval, echo time
[TE] 64 ms, slice thickness 10 mm, matrix 256 256, field
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of view 34  34 or 36  36 mm) was used to visualize
myocardial edema. Irreversible myocardial injury was visu-
alized by T1-weighted sequences (TE 23 ms, slice thickness
10 mm, matrix 256 160, field of view 36 36 cm) 20 min
after intravenous application of 0.2 mmol/kg gadolinium–
pentetic acid (Magnevist, Schering AG, Berlin, Germany).
In three patients, we also assessed myocardial necrosis, as
defined by “delayed enhancement,” using a T1-weighted,
inversion-recovery prepared gradient echo sequence (TR 5.5
ms, TE 1.4 ms, inversion time [TI] 220 to 250 ms, slice
thickness 10 mm).
We calculated the signal intensity ratio of the infarcted
myocardium compared with remote myocardium and the
proportion of the infarcted tissue related to the entire
myocardium in the infarct-containing slice.
The left ventricular ejection fraction was quantified in a
set of contiguous gradient-echo images (TE 4.8 to 6.1 ms,
slice thickness 10 mm) in the true short-axis orientation.
Cardiovascular magnetic resonance was performed before
and 58  14 min after the intervention as well as on days 1,
3, 7, 14, 28, 90, and 180. One patient (who underwent 2
interventions) had an additional study 7 h after the inter-
vention.
Care was taken to reproduce the same slice position in the
follow-up studies, using anatomic landmarks.
Statistics. The infarct area during follow-up was compared
with remote areas using an analysis of variance (Statview,
SAS Inc., Cary, North Carolina) and as a post hoc analysis
Fisher exact test.
RESULTS
All patients could be investigated without complications in
a routine clinical setting.
Septal artery embolization procedure. All septal ablation
procedures were successful, as defined by an immediate drop
in the pressure gradient and subsequent enzyme release. No
major complications occurred. Creatine kinase activity
peaked at 570  213 U/l (normal range 170 U/l for
women and 200 U/l for men) after the intervention and
normalized in all subjects within five days. In four patients,
the ECG demonstrated signs of anteroseptal MI as defined
by ST-segment elevations 0.2 mV in at least two adjacent
chest wall leads (generally leads V2 to V4).
At the end of the follow-up period, the clinical status had
improved in all patients (mean NYHA class 3.1  0.1 vs.
1.3  0.2, p  0.0001).
T2-weighted CMR. Before the intervention, the T2-
weighted images did not show any myocardial signal inten-
sity abnormalities in the basal septal region. Also, within 1 h
after the intervention, there were no relevant intramyocar-
dial signal intensity changes in T2-weighted images. In
some patients it was necessary to differentiate intramyocar-
dial signal from slow flow (Fig. 1). Therefore, a gradient-
echo sequence was used to verify the endocardial border.
Also, in the one patient with an additional CMR study 7 h
after the intervention, no significant edema was detectable
at that time point. However, 24 h after the intervention, a
signal increase in the infarct area was visible in seven of
eight patients. On days 3, 7, 14, and 28, these signal
changes were visible in all patients, whereas after 90 and 180
days they had disappeared.
Contrast-enhanced CMR. The course of signal intensity
changes in late contrast-enhanced T1-weighted CMR im-
ages differed from that of T2-weighted CMR images. The
investigated regions had no contrast enhancement before
the intervention. The signal intensity ratio between septal
and remote myocardium increased from 1.01  0.01 before
the intervention to 1.84  0.19 1 h after the intervention (p
 0.05). A localized enhancement persisted during the
entire follow-up period (Figs. 1 and 2). The intensity and
extent of the localized signal increase varied between the
patients.
The area of the infarcted region during follow-up was
significantly larger between days 1 and 14 than at all other
time points (p 0.02) in the late contrast-enhanced images.
Furthermore, significant changes in the T2-weighted CMR
images were observed. The area of the increased STIR
signal was larger than that of the late contrast-enhanced
images, but this difference did not reach statistical signifi-
cance (Fig. 2). After 180 days, the area of the signal increase
in the late contrast-enhanced images appeared more sharply
defined and smaller than on day 7.
Functional analysis. In all patients, a persisting regional
hypokinesia in the infarcted region was observed, as quan-
tified in gradient-echo CMR image series. The global left
ventricular function did not change (ejection fraction: 68 
4% vs. 69  4%, p  NS).
DISCUSSION
Our data show that contrast-enhanced CMR is able to
visualize even small myocardial infarcts in vivo at a very early
stage, whereas T2-weighted CMR may not be sufficiently
sensitive.
To our knowledge, this is the first report on CMR in
patients early after an embolic event. There is a case report
using CMR to visualize microvascular obstruction after
Abbreviations and Acronyms
AMI  acute myocardial infarction
CMR  cardiovascular magnetic resonance
ECG  electrocardiogram/electrocardiographic/
electrocardiography
MI  myocardial infarction
MR  magnetic resonance
NYHA  New York Heart Association
STIR  short T1 inversion recovery
TI E echo time
TI  inversion time
TR  repetition time
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septal artery embolization (12). However, the ablation
method in that case differed from ours by the use of alcohol.
Our findings of infarct-related contrast enhance-
ment correspond to histologic evidence of the presence
of myocardial necrosis as early as 40 min after arterial
occlusion (13,14). The same studies showed that the
infarct subsequently expands, a finding known as the
“wave front phenomenon” (13). This is associated with
the development of intracellular and interstitial myo-
cardial edema.
In our approach, ablation of the septum was performed by
applying micro-emboli consisting of foam gel, without any
alcohol. Thus, an embolic event is created, providing a
pathophysiology very similar to AMI. Thus, our model
differs from classic infarcts by a more peripheral location of
the occluding substrate and thus collateral flow. However, a
better collateral flow, albeit reducing the infarct size, is
unlikely to change the pathophysiology in the more central
parts of the infarcted area. Thus, we are convinced that our
model closely matches at least most parts of an atheroscle-
rotic, but ultimately, no-flow infarction.
There are many studies on magnetic resonance (MR)
findings in animal models of AMI. Although animal studies
have provided significant insight into early ischemic myo-
cardial injuries, studies in humans remain a necessity,
considering the different profiles of myocardial ischemic
injury in humans compared with other species. Our data
may provide the information that is lacking by using a
human model that closely matches the embolic event of
AMI.
Magnetic resonance studies in animals showed an in-
crease of T1 and T2 relaxation times 3 h after occlusion (15).
Higgins et al. (16) demonstrated in an animal model of
AMI that the increase in T2 signal of the infarcted regions
reflects infarct-associated myocardial edema. Further stud-
ies on animal models confirmed the relationship between a
high T2 signal pattern and myocardial edema and further
demonstrated that the spatial extent of myocardial edema
exceeds that of irreversible myocardial injury (17). It was
shown that diffusion-weighted MR imaging, but not T2-
weighted MR imaging, is sensitive to intracellular edema
(18). Thus, it is very likely that the high signal intensity in
our setting is reflective mainly of interstitial edema. In
humans with subacute MI, Miller et al. (19) have shown
that the function of myocardial segments showing a high
STIR signal may recover, suggesting a mismatch between
Figure 1. Signal changes in the septal myocardial infarction in a follow-up detected by magnetic resonance imaging. (a) T2-weighted spin-echo sequences
visualizing the edema. Sixty minutes after acute occlusion of the septal artery, there was no signal increase in the myocardium; the streaky artifacts visible
adjacent to the septum and in the inferior parts in both ventricles are most likely due to slow flowing blood. (b) T1-weighted spin-echo imaging after
gadolinium. Enhancment was detectable within 60 min of infarction.
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myocardial edema and necrosis. Although myocardial
edema occurs in irreversibly injured myocardium, it fre-
quently also extends to reversibly injured myocardium and
was shown to closely match the myocardial “area at risk” (9).
Our results indicate a differential time course of contrast
enhancement, reflecting irreversible myocardial injury, and a
high T2 signal intensity, reflecting myocardial edema with a
delay in the occurrence of T2-related changes. Thus, for very
early detection in a clinical setting, this approach does not
seem to be sufficiently sensitive.
These results correspond to several animal studies show-
ing that infarct-related myocardial edema was not detectable
within the first hour before, but by 3 h after, occlusion
(9,15,20). Different mechanisms may explain this. It is
known that early in the course of ischemic injury myocardial
edema is predominantly intracellular, and T2-weighted
CMR may not be able to detect bound water molecules in
the case of intracellular edema.
Later on, however, a T2-related high signal was consis-
tently observed. There are no published in vivo human data
on patients with edema in the very early stages of MI, but an
increased signal intensity in T2-weighted images was re-
ported for infarcted regions three days after MI, which
could be correlated with myocardial edema (21,22). We also
found evidence of edema one day after AMI, consistent
with these results. The edema persisted for at least one
month but was not detectable after three months.
In contrast to T2 changes, T1 abnormalities due to MI are
typically not visually detectable on MR images without
using contrast agents.
On the other hand, CMR imaging late after administra-
tion of gadolinium (delayed enhancement) accurately re-
flects irreversible myocardial injury. In contrast to T2-
weighted images, only irreversibly damaged myocardium is
enhanced. Thus, it is conceivable that the spatial extent of
delayed enhancement would be less than that of STIR-
determined myocardial edema.
Reperfusion injury early after experimental MI has been
assessed by contrast-enhanced CMR (23,24), and there are
numerous studies indicating that contrast-enhanced CMR
is able to differentiate between infarcted and viable myocar-
dium (6,25,26). The agreement of gadolinium accumulation
with histologic parameters of myocardial necrosis was
shown in animal CMR studies as early as 6 h after AMI
(27,28).
The underlying pathophysiology of gadolinium accumu-
lation in MI, however, has not been fully elucidated.
Mechanisms under discussion include a prolonged wash-in/
wash-out period in the infarcted tissue due to contrast
media diffusion into necrotic cells, as well as a relative
increase of interstitial space and interstitial edema (29,30).
Thus, the contribution of edema, by comparison with
necrosis or fibrosis, to the accumulation of gadolinium is
difficult to estimate.
Interestingly, we observed a transient spatial increase of
the enhancing area in the contrast-enhanced T1-weighted
images during the period with edema, as defined by high
signal intensity areas in the T2-weighted images, indicating
a common underlying pathophysiology. Different mecha-
nisms may explain this finding: it has been previously shown
that in humans, the time needed for the infarct to reach its
maximum size is about 6 to 12 h, compared with 3 to 4 h in
dogs. Furthermore, gadolinium–pentetic acid also accumu-
lates in edema (31), and thus our finding may simply reflect
the involvement of infarct-associated edema. Finally, recent
reports have underlined the role of apoptosis in the patho-
physiologic cascade of irreversible ischemic injury. It is
assumed that the apoptotic process achieves its final spatial
extent a few days after the ischemic insult.
In patients with two infarctions, the more recent acute
infarct revealed more blurred edges of the infarct-related
necrosis than the chronic scar. Furthermore, signal intensity
increased to a lesser extent. A clear discrimination of both
infarcts, however, was possible only by the presence or
absence of the infarct-associated edema (Fig. 3).
Thus, a delayed contrast enhancement without concom-
itant edema may be a marker of either necrosis during the
first hours of infarction or chronic myocardial scar (after
infarct-related inflammation has disappeared).
Clinical implications. Our results underscore the potential
role of CMR in a number of clinical scenarios. Verifying the
diagnosis of AMI is useful in the critical care setting, when
conventional methods are inconclusive or contradictory and
a therapeutic decision is urgently required. In addition,
differentiation between acute and chronic infarcts is also
possible. In the case of known infarcts, their age can be
estimated: the finding of delayed enhancement in the
absence of a corresponding high STIR signal intensity
would exclude an acute event.
Finally, the unique ability of CMR to provide a non-
invasive, reproducible means of assessing the temporal
Figure 2. Changes over time in the infarcted and edematous areas. The
affected area (%)  (area with signal abnormality/area of whole myocar-
dium within slice)  100. *Significant difference from day 0 (1 h after
intervention) and days 28, 90, and 180 (p  0.05). #Significant difference
from days 1, 3, 7, 14, and 28 (p 0.05). ##Significant difference from days
3 and 7 (p  0.05). STIR  short T1 inversion recovery.
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evolution and spatial extent of various myocardial ischemic
injuries may justify its application as a tool for monitoring
the effect of novel therapeutic approaches targeting these
injuries.
Study limitations. Our study was performed on a specific
patient population without chronic coronary artery disease.
Although septal artery embolization produces an acute,
non-reperfused MI, the injurious profile of this rather
“controlled” myocardial insult may differ from the complex
pathophysiology underlying clinical AMI.
We also did not register images, and despite our efforts to
accurately reproduce the previous position with the help of
anatomic landmarks, a slight shift of the position may have
occurred.
Finally, because of the time we started our investigations,
no inversion-prepared T1-weighted gradient-echo se-
quence, as is usually used today for late enhancement CMR,
was available. However, our experience with patients in
whom both sequences were applied, did not reveal any
significant differences between our and the newer tech-
niques. Although newer techniques have a better contrast–
noise relation, T1-weighted sequences in general reveal the
post-contrast signal changes we observed.
Conclusions. Contrast-enhanced T1-weighted CMR is a
sensitive method of detecting myocardial tissue damage
even within 1 h after an acute embolic MI in humans,
whereas T2-weighted CMR was found to be not sufficiently
sensitive at this early time point.
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